Nareena Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 29-12-2024
- Paid Up Capital ₹ 5.00 M
as on 29-12-2024
- Company Age 9 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.23 Cr
as on 29-12-2024
- Revenue 194.03%
(FY 2021)
- Profit 32.62%
(FY 2021)
- Ebitda 53.41%
(FY 2021)
- Net Worth 62.23%
(FY 2021)
- Total Assets 97.26%
(FY 2021)
About Nareena Lifesciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹4.23 Cr.
Navinkumar Singh and Reena Singh serve as directors at the Company.
- CIN/LLPIN
U51101UP2015PTC071432
- Company No.
071432
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jun 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Gautam Buddha Nagar, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Nareena Lifesciences Private Limited offer?
Nareena Lifesciences Private Limited offers a wide range of products and services, including Oxygen Concentrator, Patient Monitoring System, Cardiac & Multi Parameter Patient Monitor, Suction Machine, Electric Suction Unit, Surgical & ICU Equipments, Medical Pumps, CPAP, BiPAP Machine & Accessories, CPAP Machine, BiPAP Machine.
Who are the key members and board of directors at Nareena Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Navinkumar Singh  | Director | 18-Jun-2015 | Current |
| Reena Singh | Additional Director | 12-Mar-2024 | Current |
Financial Performance of Nareena Lifesciences.
Nareena Lifesciences Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 194.03% increase. The company also saw a substantial improvement in profitability, with a 32.62% increase in profit. The company's net worth Soared by an impressive increase of 62.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nareena Lifesciences?
In 2021, Nareena Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 03 Sep 2021 | ₹9.70 M | Open |
Hdfc Bank Limited Creation Date: 21 Nov 2020 | ₹3.26 Cr | Open |
How Many Employees Work at Nareena Lifesciences?
Nareena Lifesciences has a workforce of 7 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nareena Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nareena Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
